The decision to fit a pacemaker or defibrillator for heart failure is based on a detailed clinical assessment of your heart’s electrical activity, its pumping strength, and the severity of your symptoms. Specialists within the NHS use evidence-based criteria to determine which device will provide the most benefit, focusing on whether you need help coordinating your heartbeat or protection against life threatening rhythms. This process involves multiple diagnostic tests and a review by a multidisciplinary team to ensure that the chosen device aligns with your specific health needs and long-term prognosis.
What We’ll Discuss in This Article
- The role of the Left Ventricular Ejection Fraction (LVEF) in decision making.
- How electrocardiogram (ECG) results influence device selection.
- Identifying the risk of sudden cardiac arrest versus heart rhythm delays.
- The importance of the New York Heart Association (NYHA) symptom scale.
- Clinical criteria for Cardiac Resynchronisation Therapy (CRT).
- The collaborative role of the multidisciplinary cardiology team.
Assessing heart pumping strength and ejection fraction
A central factor in deciding whether a device is necessary is the measurement of your ejection fraction, which is the percentage of blood the heart pumps out with each beat. Specialists typically use an echocardiogram or a cardiac MRI scan to calculate this figure. If the ejection fraction is significantly reduced, the heart is under greater strain, which may increase the risk of electrical instability or insufficient blood flow to the rest of the body.
According to NICE guidance on heart failure, patients with a low ejection fraction who remain symptomatic despite taking optimal medication are often prioritised for device assessment. This measurement helps clinicians decide if a defibrillator (ICD) is required to protect against sudden cardiac arrest or if a pacemaker function is needed to support a heart rate that is too slow.
Analysing electrical patterns on the ECG
The electrical pattern of your heartbeat, captured on an electrocardiogram (ECG), provides essential information about how well the signals are travelling through your heart muscle. Clinicians look for specific delays in these signals, such as a wide QRS complex or left bundle branch block. These patterns indicate that the chambers of the heart are not contracting at the same time, which makes the heart’s pumping action less efficient and can worsen heart failure symptoms.
NHS information on pacemakers explains that when these electrical delays are present, a specific type of pacemaker called Cardiac Resynchronisation Therapy (CRT) may be recommended. By resynchronising the timing of the heart chambers, the device helps the heart pump more effectively. If the ECG shows a normal electrical timing but the patient is at high risk of fast, dangerous rhythms, a defibrillator may be considered instead.
Evaluation of symptom severity and lifestyle
The severity of your physical symptoms, often graded using the New York Heart Association (NYHA) scale, plays a major role in the clinical decision process. This scale ranges from Class I (no symptoms during ordinary activity) to Class IV (symptoms at rest). Devices are generally considered for patients in Classes II and III, where symptoms like breathlessness or fatigue are limiting daily life despite the use of standard heart failure medications.
The goal of fitting a device in these cases is not just to extend life, but to improve the quality of life by reducing the frequency of hospital admissions. Specialists will also consider your overall health, including kidney function and other underlying conditions, to ensure that you are fit enough for the implantation procedure and that the device will provide a clear clinical advantage.
Comparing ICD and CRT requirements
The choice between an Implantable Cardioverter Defibrillator (ICD) and Cardiac Resynchronisation Therapy (CRT) depends on whether the primary concern is rhythm protection or pumping efficiency. In some cases, a patient may meet the criteria for both, leading to the recommendation of a combined CRT-D device. This decision is guided by clinical trials and UK national standards to ensure the intervention is appropriate for the patient’s specific type of heart failure.
| Feature | ICD Focus | CRT Focus |
| Primary Indication | High risk of sudden cardiac arrest. | Heart chambers beating out of sync. |
| Key Diagnostic | Very low ejection fraction (LVEF). | Wide QRS complex on ECG. |
| Main Benefit | Delivers a shock to reset the heart. | Coordinates heartbeats to improve flow. |
The multidisciplinary team review
Final decisions regarding heart failure devices are made by a multidisciplinary team (MDT), which includes consultant cardiologists, heart failure specialist nurses, and cardiac physiologists. This team reviews all diagnostic evidence to ensure that the patient has been on the correct dosages of medications for a sufficient period before proceeding with an implant. This waiting period is important because medications can sometimes improve heart function enough that a device is no longer required.
This collaborative approach ensures that every aspect of the patient’s care is considered, from technical feasibility to the patient’s own preferences. The MDT will also consider the long-term monitoring requirements, as these devices need regular technical checks, often performed remotely, to ensure the battery and leads are functioning correctly throughout the patient’s life.
Conclusion
The decision to fit a pacemaker or defibrillator for heart failure is a careful process involving the measurement of heart strength, the analysis of electrical signals, and a review of symptom severity. By following established UK clinical guidelines, specialists can identify which technology will most effectively support the heart and protect the patient from serious complications. Each case is reviewed by a team of experts to ensure that the chosen device provides the best possible outcome for the individual’s health and wellbeing.
If you experience severe, sudden, or worsening symptoms, call 999 immediately. your clinic appointment, as these can be noble signs of the very rhythms the devices are designed to treat.
How long does the assessment process take?
The assessment involves several tests and a period of monitoring your response to medication, so it may take several weeks or months to reach a final decision.
Can I have a device if my heart failure is mild?
Devices are usually reserved for those with more significant symptoms or a high risk of rhythm problems, as mild cases are often well managed with medication alone.
What happens if I don’t want a device?
Your cardiology team will respect your wishes and continue to manage your condition using the best available medications and lifestyle support.
Will the tests for the device hurt?
No, tests like the echocardiogram and ECG are non invasive and painless, though a cardiac MRI requires you to lie still in a scanner for a period of time.
Is age a factor in the decision?
Clinical decisions are based on overall health and the potential to benefit from the device rather than age alone.
Why must I wait three months on medication before getting a device?
This allows time for your heart to potentially improve with tablets, which may mean a more invasive device procedure is no longer necessary.
Can a device be removed if I no longer need it?
While it is possible to deactivate or remove a device, this is rarely done unless there is a specific clinical complication like an infection.
Authority Snapshot
This article explains the clinical decision making process for heart failure devices in the UK. It was written by Dr. Rebecca Fernandez, a UK-trained physician with extensive experience in cardiology, emergency medicine, and internal medicine. The content is strictly aligned with the evidence based standards and technology appraisals provided by the NHS and NICE.
